- Home
- CNTX vs UCL Comparison
CNTX vs UCL Comparison
Compare CNTX & UCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNTX
- UCL
- Stock Information
- Founded
- CNTX 2015
- UCL 2014
- Country
- CNTX United States
- UCL Hong Kong
- Employees
- CNTX N/A
- UCL N/A
- Industry
- CNTX Biotechnology: Pharmaceutical Preparations
- UCL Telecommunications Equipment
- Sector
- CNTX Health Care
- UCL Consumer Discretionary
- Exchange
- CNTX Nasdaq
- UCL Nasdaq
- Market Cap
- CNTX 78.0M
- UCL 65.9M
- IPO Year
- CNTX 2021
- UCL 2020
- Fundamental
- Price
- CNTX $0.58
- UCL $1.83
- Analyst Decision
- CNTX Strong Buy
- UCL
- Analyst Count
- CNTX 4
- UCL 0
- Target Price
- CNTX $6.00
- UCL N/A
- AVG Volume (30 Days)
- CNTX 390.0K
- UCL 96.8K
- Earning Date
- CNTX 08-06-2025
- UCL 08-13-2025
- Dividend Yield
- CNTX N/A
- UCL N/A
- EPS Growth
- CNTX N/A
- UCL N/A
- EPS
- CNTX N/A
- UCL 0.09
- Revenue
- CNTX N/A
- UCL $92,256,000.00
- Revenue This Year
- CNTX N/A
- UCL $6.09
- Revenue Next Year
- CNTX N/A
- UCL $7.01
- P/E Ratio
- CNTX N/A
- UCL $19.83
- Revenue Growth
- CNTX N/A
- UCL 7.65
- 52 Week Low
- CNTX $0.49
- UCL $0.80
- 52 Week High
- CNTX $2.75
- UCL $3.30
- Technical
- Relative Strength Index (RSI)
- CNTX 44.00
- UCL 61.19
- Support Level
- CNTX $0.56
- UCL $1.75
- Resistance Level
- CNTX $0.63
- UCL $2.27
- Average True Range (ATR)
- CNTX 0.08
- UCL 0.15
- MACD
- CNTX 0.00
- UCL -0.01
- Stochastic Oscillator
- CNTX 27.68
- UCL 42.99
About CNTX Context Therapeutics Inc.
Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of various therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody (bsAb) that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.
About UCL uCloudlink Group Inc.
Ucloudlink Group Inc is engaged in the provision of data connectivity services and sales of Wi-Fi terminals and data related products to enable personal and enterprise users to access mobile internet in more than 100 countries and areas. Leveraging its inventive cloud SIM technology and architecture, the company redefine the mobile data connectivity experience, allowing users to gain access to mobile data traffic allowance shared by network operators on its marketplace. It has aggregated mobile data traffic allowances from 391 MNOs in 163 countries and regions in its cloud SIM architecture. The company derives maximum revenue from Japan.